source
stringlengths 2
222
| date
stringlengths 19
19
| url
stringlengths 22
853
⌀ | text
stringlengths 0
10k
⌀ | title
stringlengths 0
701
| context_id
stringlengths 1
9
| document_id
stringclasses 2
values | document_type
stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Business Wire | 2021-06-24 14:48:00 | https://www.businesswire.com/news/home/20210624005948/en/Macquarie-Asset-Management-and-Wilshire-Expand-Access-to-Private-Market-Investment-Solutions-for-Accredited-Investors-with-the-Launch-of-Delaware-Wilshire-Private-Markets-Fund/ | PHILADELPHIA & SANTA MONICA, Calif.--(BUSINESS WIRE)--Macquarie Asset Management (Macquarie) and Wilshire Advisors LLC (Wilshire) today announced that Delaware Wilshire Private Markets Fund (the Fund), a first-of-its-kind offering, is available for accredited investors, providing efficient access to an institutional-quality diversified private markets portfolio, including private equity, private credit, alternative yield, and private real assets. “The launch of Delaware Wilshire Private Markets | Macquarie Asset Management and Wilshire Expand Access to Private Market Investment Solutions for Accredited Investors with the Launch of Delaware Wilshire Private Markets Fund | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-06-23 11:17:10 | https://www.zacks.com/stock/news/1752997/agilent-a-expands-presence-in-lc-market-with-new-systems | Agilent (A) expands its Bio Liquid Chromatography solutions portfolio with three new systems to fulfil the needs of biopharma industry. | Agilent (A) Expands Presence in LC Market With New Systems | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-06-22 03:00:00 | https://www.businesswire.com/news/home/20210622005072/en/Agilent-Completes-the-InfinityLab-Bio-LC-Portfolio/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma industry. The release is central to the Agilent portfolio of complete Bio LC solutions, featuring instruments, columns, and supplies that seamlessly integrate with Agilent OpenLab and MassHunter software, and CrossLab services to maximize efficiency in biopharma labs. The three new systems include the 1 | Agilent Completes the InfinityLab Bio LC Portfolio | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-06-18 09:47:39 | https://www.zacks.com/stock/news/1727488/new-to-investing-this-1-computer-and-technology-stock-could-be-the-perfect-starting-point | Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service. | New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-06-17 12:02:07 | https://www.zacks.com/stock/news/1722768/is-agilent-technologies-a-stock-outpacing-its-computer-and-technology-peers-this-year | Is (A) Outperforming Other Computer and Technology Stocks This Year? | Is Agilent Technologies (A) Stock Outpacing Its Computer and Technology Peers This Year? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-06-14 13:32:15 | https://www.zacks.com/stock/news/1706138/surging-earnings-estimates-signal-upside-for-agilent-a-stock | Agilent (A) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. | Surging Earnings Estimates Signal Upside for Agilent (A) Stock | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-06-04 08:00:00 | https://www.businesswire.com/news/home/20210604005066/en/Cell-Free-DNA-Guided-Targeted-Therapy-Leads-to-Better-Survival-in-Advanced-Non-Small-Cell-Lung-Cancer/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a presentation by Memorial Sloan Kettering Cancer Center (MSK) at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO) to discuss the Resolution ctDx Lung, a laboratory-developed test (LDT) developed by Resolution Bioscience. The presentation titled Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer will present evidence for the clin | Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-06-01 08:45:14 | https://seekingalpha.com/article/4432356-agilent-expensive-yet-safe-bet | Agilent has been a stealth value-creating play over the past years. | Agilent: Expensive, Yet Safe Bet | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2021-05-27 18:25:05 | https://www.gurufocus.com/news/1440737/agilents-4th-consecutive-beat-on-earnings-boosts-stock | On the heels of a bang-up second quarter, Agilent Technologies Inc. (A) shares climbed more than 3% to $137.58 on Thursday. The Santa Clara, California-based provider of application-focused solutions to the life sciences, diagnostics and applied chemical markets has beaten earnings estimates in each of the past four quarters. | Agilent's 4th Consecutive Beat on Earnings Boosts Stock | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-05-26 09:01:07 | https://www.zacks.com/stock/news/1608665/agilent-a-q2-earnings-revenues-beat-estimates-rise-y-y | Agilent's (A) fiscal second-quarter results benefit from strength across all geographical regions and end-market momentum. | Agilent (A) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2021-05-26 08:53:15 | https://www.benzinga.com/analyst-ratings/21/05/21296359/what-12-analyst-ratings-have-to-say-about-agilent-technologies | Analysts have provided the following ratings for Agilent Technologies (NYSE:A) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 0 0 1 Somewhat Bullish 4 0 0 0 Indifferent 0 0 0 0 Somewhat Bearish 0 0 0 0 Bearish 0 0 0 0 In the last 3 months, 12 analysts have offered 12-month price targets for Agilent Technologies. The company has an average price target of $145.08 with a high of $160.00 and a low of $135.00. | What 12 Analyst Ratings Have To Say About Agilent Technologies | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-05-25 23:27:10 | https://seekingalpha.com/article/4431288-agilent-technologies-inc-ceo-mike-mcmullen-on-q2-2021-results-earnings-call-transcript | Agilent Technologies Inc. (A) CEO Mike McMullen on Q2 2021 Results - Earnings Call Transcript | Agilent Technologies Inc. (A) CEO Mike McMullen on Q2 2021 Results - Earnings Call Transcript | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-05-25 18:02:03 | https://www.zacks.com/stock/news/1605267/agilent-technologies-a-q2-earnings-and-revenues-beat-estimates | Agilent (A) delivered earnings and revenue surprises of 18.29% and 9.91%, respectively, for the quarter ended April 2021. Do the numbers hold clues to what lies ahead for the stock? | Agilent Technologies (A) Q2 Earnings and Revenues Beat Estimates | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2021-05-25 16:20:13 | https://www.benzinga.com/news/earnings/21/05/21286800/recap-agilent-technologies-q2-earnings | Shares of Agilent Technologies (NYSE:A) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 36.62% over the past year to $0.97, which beat the estimate of $0.83. | Recap: Agilent Technologies Q2 Earnings | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-05-25 16:05:00 | https://www.businesswire.com/news/home/20210525005835/en/Agilent-Reports-Second-Quarter-Fiscal-Year-2021-Financial-Results/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces second quarter financial results; raises full-year guidance. | Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2021-05-24 10:05:04 | https://www.benzinga.com/news/earnings/21/05/21258854/earnings-outlook-for-agilent-technologies | Agilent Technologies (NYSE:A) unveils its next round of earnings this Tuesday, May 25. Here is Benzinga's everything-that-matters guide for the earnings announcement. | Earnings Outlook For Agilent Technologies | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-05-20 14:17:05 | https://www.zacks.com/stock/news/1582664/agilent-a-to-report-q2-earnings-whats-in-the-offing | Agilent's (A) fiscal second-quarter results are expected to reflect portfolio strength and end-market momentum. | Agilent (A) to Report Q2 Earnings: What's in the Offing? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-05-20 13:12:00 | https://www.businesswire.com/news/home/20210520005918/en/Agilent-to-Present-at-Jefferies-Virtual-Healthcare-Conference/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #A--Agilent to present at Jefferies Virtual Healthcare Conference June 1. | Agilent to Present at Jefferies Virtual Healthcare Conference | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-05-19 16:05:00 | https://www.businesswire.com/news/home/20210519005862/en/Agilent-Announces-Cash-Dividend-of-19.4-Cents-per-Share/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces quarterly dividend. | Agilent Announces Cash Dividend of 19.4 Cents per Share | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-05-18 15:47:12 | https://www.zacks.com/stock/news/1572071/agilent-technologies-a-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release | Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-05-13 10:51:00 | https://www.businesswire.com/news/home/20210513005716/en/Macquarie-Asset-Management-Appoints-Michael-Kopfler-Global-Head-of-Equity-Trading/ | PHILADELPHIA--(BUSINESS WIRE)--Macquarie Asset Management today announced the appointment of Michael Kopfler as Global Head of Equity Trading reporting to John Leonard, Global Head of Equities at the firm. In this role, Michael will be responsible for the strategic direction, daily operation, and management of Macquarie Asset Management's global equity trading desk, including maximizing technology and analytics and implementing innovative trading solutions to enhance client outcomes. “Michael b | Macquarie Asset Management Appoints Michael Kopfler Global Head of Equity Trading | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-05-07 08:16:08 | https://www.zacks.com/stock/news/1515351/6-must-buy-stocks-ahead-of-earnings-results-this-month | We have narrowed down our search to six major stocks likely to gain on earnings results. These are TGT, RL, KSS, NVDA, HPQ and A. | 6 Must-Buy Stocks Ahead of Earnings Results This Month | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2021-05-06 16:41:26 | https://investorplace.com/2021/05/5-cheap-growth-stocks-for-q2-2021/ | After a brief selloff in Q1 2021, growth stocks are once again in focus. Investors can take advantage of this by investing in growth companies trading at low valuations. | 5 Cheap Growth Stocks for Q2 2021 | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-05-03 15:00:00 | https://www.businesswire.com/news/home/20210503005613/en/Agilent-to-Webcast-Second-Quarter-Fiscal-Year-2021-Financial-Results-Presentation/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent to announce fiscal second quarter financial results on May 25. | Agilent to Webcast Second-Quarter Fiscal Year 2021 Financial Results Presentation | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-04-22 08:02:00 | https://www.businesswire.com/news/home/20210422005614/en/Agilent-LCMS-Instruments-Receive-ACT-Labels-from-My-Green-Lab/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that both the InfinityLab LC/MSD iQ and the Ultivo Triple Quadrupole LC/MS systems have earned the highly-respected Accountability, Consistency and Transparency (ACT) Label from My Green Lab, a nonprofit organization dedicated to improving the sustainability of scientific research. “Agilent's mission is to provide trusted answers and insights that advance the quality of life, and sustainability is an impor | Agilent LC/MS Instruments Receive ACT Labels from My Green Lab | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-04-20 12:19:00 | https://www.businesswire.com/news/home/20210420005956/en/Agilent-Named-One-of-the-Best-U.S.-Companies-for-Diversity-for-Third-Straight-Year/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies (NYSE: A) today was named one of the top U.S. companies for diversity, marking the third straight year it has been recognized for its commitment to fostering a diverse and inclusive workplace. Specifically, Agilent ranked No. 83 out of 500 companies on Forbes's 2021 list of America's Best Employers for Diversity. The rating was based on dimensions of diversity including gender, ethnicity, LGBTQ+, age, and the differently abled. Agilent | Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-04-19 15:52:00 | https://www.businesswire.com/news/home/20210419005858/en/Macquarie-Asset-Management-Launches-%E2%80%9CThe-Sharpe-Advisor%E2%80%9D-Digital-Educational-Platform-for-Advisors-Centered-Around-Private-Markets/ | PHILADELPHIA--(BUSINESS WIRE)--Macquarie Asset Management (“MAM”) today announced the launch of The Sharpe Advisor, a specialized digital resource for financial advisors that provides comprehensive educational content on private markets. With education as a key driver of success in bringing alternative investment solutions to financial advisors and their clients, Macquarie Asset Management aims to serve advisors with a practical guide to private markets investing with specialized content from i | Macquarie Asset Management Launches “The Sharpe Advisor” Digital Educational Platform for Advisors Centered Around Private Markets | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-04-13 20:00:00 | https://www.businesswire.com/news/home/20210413006097/en/Agilent-Named-One-of-Singapore%E2%80%99s-Best-Employers/ | SINGAPORE--(BUSINESS WIRE)--Agilent Technologies announced that Agilent Singapore has been recognized as one of Singapore's Best Employers in 2021 for the second year-in-a-row. | Agilent Named One of Singapore's Best Employers | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-04-08 12:52:18 | https://www.zacks.com/stock/news/1365233/agilent-a-moves-to-strong-buy-rationale-behind-the-upgrade | Agilent (A) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. | Agilent (A) Moves to Strong Buy: Rationale Behind the Upgrade | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-03-31 18:47:46 | https://seekingalpha.com/article/4417096-agilent-leveraged-to-post-pandemic-recovery-and-advanced-drug-discovery-and-production | Agilent isn't a conventionally cheap stock, but should offer above-average revenue growth and margin expansion over the next five to 10 years, with leverage to several growth segments with biopharma. Agilent has been gaining share in instruments and demand should improve as lab activities and budgets normalize after the pandemic, with automation a longer-term growth driver. | Agilent Leveraged To Post-Pandemic Recovery And Advanced Drug Discovery And Production | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-03-31 06:00:00 | https://www.businesswire.com/news/home/20210331005402/en/%C2%A0Oxford-BioDynamics-signs-supply-and-resale-agreement-with-Agilent-Technologies-and-launches-EpiSwitch%C2%AE-Explorer-Array-Kit-for-RD-use/ | OXFORD, England--(BUSINESS WIRE)--Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests for personalized healthcare based on the EpiSwitch® 3D genomics platform, and Agilent Technologies (NYSE: A), a global leader in the life sciences, diagnostics, and applied chemical markets, have signed a supply and resale agreement for the manufacture and sale of the new EpiSwitch® Explorer Array Kit (“Kit”). Under the terms of the agreement, Agilent wil | Oxford BioDynamics signs supply and resale agreement with Agilent Technologies, and launches EpiSwitch® Explorer Array Kit for R&D use | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2021-03-29 16:39:06 | https://www.gurufocus.com/news/1390096/bill-ackmans-pershing-square-2020-annual-letter-to-shareholder | To the Shareholders of Pershing Square Holdings, Ltd.: 2020 was the best year in the 17-year history of Pershing Square. | Bill Ackman's Pershing Square 2020 Annual Letter to Shareholder | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-03-18 12:30:43 | https://www.zacks.com/stock/news/1282090/why-is-agilent-a-down-58-since-last-earnings-report | Agilent (A) reported earnings 30 days ago. What's next for the stock? | Why Is Agilent (A) Down 5.8% Since Last Earnings Report? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-03-17 16:05:00 | https://www.businesswire.com/news/home/20210317005785/en/Agilent-Announces-Cash-Dividend-of-19.4-Cents-per-Share/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces quarterly dividend. | Agilent Announces Cash Dividend of 19.4 Cents per Share | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-03-16 09:51:22 | https://www.zacks.com/stock/news/1280547/agilent-a-boosts-intelligence-capability-with-a-new-launch | Agilent (A) unveils 8697 Headspace Sampler which unprecedented precision and strong connections. | Agilent (A) Boosts Intelligence Capability With a New Launch | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-03-03 17:56:00 | https://www.businesswire.com/news/home/20210303006030/en/Agilent-Technologies-Announces-Pricing-of-850-Million-of-Senior-Notes/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies announces pricing of $850 million of senior notes. | Agilent Technologies Announces Pricing of $850 Million of Senior Notes | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-03-03 08:40:00 | https://www.businesswire.com/news/home/20210303005579/en/Agilent-Technologies-Announces-Proposed-Offering-of-Senior-Notes/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies announces proposed offering of senior notes. | Agilent Technologies Announces Proposed Offering of Senior Notes | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-03-02 02:00:00 | https://www.businesswire.com/news/home/20210301006078/en/Agilent-Announces-Darlene-Solomon-Award-Presented-to-University-of-Geneva-Scientist-Noemi-Jim%C3%A9nez-Rojo/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the recipient of the 2021 Darlene Solomon Award is Noemi Jiménez-Rojo, a postdoctoral fellow studying membrane biology, lipid diversity, and function at the University of Geneva. The award was presented at a virtual ceremony during the International Singapore Lipid Symposium (iSLS) being held March 1-5 in Singapore. “Multidisciplinary approaches that include mass spectrometry will be crucial in the fo | Agilent Announces Darlene Solomon Award Presented to University of Geneva Scientist Noemi Jiménez-Rojo | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-02-22 13:46:00 | https://www.businesswire.com/news/home/20210222005789/en/Agilent-PD-L1-IHC-22C3-pharmDx-Receives-Expanded-FDA-Approval-in-Non-small-Cell-Lung-Cancer-NSCLC/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's PD-L1 IHC 22C3 pharmDx assay for expanded use in patients with non-small cell lung cancer (NSCLC). PD-L1 IHC 22C3 pharmDx can now be used as an aid in identifying NSCLC patients with tumor PD-L1 expression of Tumor Proportion Score (TPS) ≥ 50% for treatment with Libtayo® (cemiplimab-rwlc). This announcement underscores Agilent's co | Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC) | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2021-02-19 14:15:50 | https://www.gurufocus.com/news/1364658/bill-ackman-slims-down-top-holdings-in-4th-quarter | Bill Ackman ( Trades , Portfolio ), leader of Pershing Square Capital, has revealed his portfolio for the fourth quarter of 2020. The top five trades of the quarter were reductions made in Starbucks Corp. (NASDAQ:SBUX), Restaurant Brands International Inc. (NYSE:QSR), Lowe's Companies Inc. (NYSE:LOW), Agilent Technologies Inc. (NYSE:A) and Hilton Worldwide Holdings Inc. (NYSE:HLT). | Bill Ackman Slims Down Top Holdings in 4th Quarter | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-02-18 17:36:00 | https://www.businesswire.com/news/home/20210218006089/en/Agilent-Ranks-No.-2-on-Barron%E2%80%99s-List-of-America%E2%80%99s-Most-Sustainable-Companies/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has earned the number two position on Barron's annual list of America's Most Sustainable Companies. The ranking marks the third straight year Agilent has been included among the top three Most Sustainable Companies. Agilent has also received the number one ranking in the life sciences industry for each of the four years the Barron's ranking has been compiled. “We're very pleased to again be named one of America's Most Sus | Agilent Ranks No. 2 on Barron's List of America's Most Sustainable Companies | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-02-18 08:00:00 | https://www.businesswire.com/news/home/20210218005306/en/Agilent-Announces-Immunoassay-Kit-to-Detect-SARS-CoV-2-Antibodies/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma. The kit, which marks Agilent's entrance into SARS-CoV-2 testing in the US, has completed the notification process to FDA in accordance with Section IV.D of FDA's “Policy for Coronavirus Disease-2019 Te | Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-02-17 10:36:45 | https://www.zacks.com/stock/news/1264455/agilents-a-q1-earnings-beat-estimates-revenues-up-y-y | Agilent Technologies' (A) fiscal first-quarter results reflect growth in all segments and regions served. | Agilent's (A) Q1 Earnings Beat Estimates, Revenues Up Y/Y | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-02-17 08:00:00 | https://www.businesswire.com/news/home/20210217005173/en/Agilent-Announces-Higher-Sensitivity-XF-Analysis-Solution-for-Low-Abundant-Immune-Cell-Metabolic-Analysis/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced the Agilent Seahorse XF HS Miniplate designed specifically for the Agilent Seahorse XF HS Mini Analyzer for improved immune cell metabolic analysis. Immunology and disease researchers are increasingly using rare, ex vivo, and genetically engineered cells to build better disease models. Limitations in the quantities of these cells that they can produce, however, restrict these researchers in the types of c | Agilent Announces Higher-Sensitivity XF Analysis Solution for Low Abundant Immune Cell Metabolic Analysis | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-02-16 21:29:04 | https://seekingalpha.com/article/4406522-agilent-technologies-inc-ceo-mike-mcmullen-on-q1-2021-results-earnings-call-transcript | Agilent Technologies Inc. (A) CEO Mike McMullen on Q1 2021 Results - Earnings Call Transcript | Agilent Technologies Inc. (A) CEO Mike McMullen on Q1 2021 Results - Earnings Call Transcript | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2021-02-16 16:20:52 | https://www.benzinga.com/news/earnings/21/02/19688492/recap-agilent-technologies-q1-earnings | Shares of Agilent Technologies (NYSE:A) moved higher after the company reported Q1 results. Quarterly Results Earnings per share rose 30.86% over the past year to $1.06, which beat the estimate of $0.89. | Recap: Agilent Technologies Q1 Earnings | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2021-02-16 16:10:55 | https://www.marketwatch.com/story/agilent-technologies-shares-up-2-on-better-than-expected-earnings-sales-2021-02-16 | Shares of Agilent Technologies Inc. were up 2% in after-hours trading Tuesday after the life-sciences and diagnostics company reported fiscal first-quarter results. Agilent reported net income of $288 million, or 93 cents a share, compared with net income of $197 million, or 63 cents a share, in the year-ago quarter. | Agilent Technologies shares up 2% on better-than-expected earnings, sales | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-02-16 16:05:00 | https://www.businesswire.com/news/home/20210216006023/en/Agilent-Reports-First-Quarter-Fiscal-Year-2021-Financial-Results/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #AgilentQ1--Agilent announces strong first quarter financial results; raises outlook for full year. | Agilent Reports First-Quarter Fiscal Year 2021 Financial Results | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-02-12 10:37:47 | https://www.zacks.com/stock/news/1262392/is-a-surprise-coming-for-agilent-a-this-earnings-season | Agilent (A) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. | Is a Surprise Coming for Agilent (A) This Earnings Season? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-02-12 08:20:06 | https://www.zacks.com/stock/news/1262239/whats-in-the-offing-for-agilent-a-this-earnings-season | Agilent's (A) strength in revenue segments is likely to reflect on fiscal first-quarter results. | What's in the Offing for Agilent (A) This Earnings Season? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-02-09 13:38:58 | https://www.zacks.com/stock/news/1260110/agilent-technologies-a-earnings-expected-to-grow-should-you-buy | Agilent (A) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | Agilent Technologies (A) Earnings Expected to Grow: Should You Buy? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-02-09 12:53:33 | https://www.zacks.com/stock/news/1260054/what-makes-agilent-a-a-new-buy-stock | Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). | What Makes Agilent (A) a New Buy Stock | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-02-08 14:00:00 | https://www.businesswire.com/news/home/20210208005649/en/Agilent-to-Present-at-Upcoming-Investor-Events-Provides-Webcast-Details-for-Annual-Shareholder-Meeting/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces upcoming investor events and details for annual Shareholder Meeting. | Agilent to Present at Upcoming Investor Events; Provides Webcast Details for Annual Shareholder Meeting | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-02-01 11:00:00 | https://www.businesswire.com/news/home/20210201005175/en/Agilent-Wins-Trade-Secret-and-Patent-Infringement-Litigation/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent wins trade secret and patent Infringement ruling; J&X Technologies to pay Agilent more than $1.25 million in damages. | Agilent Wins Trade Secret and Patent Infringement Litigation | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-01-27 22:31:17 | https://seekingalpha.com/article/4401483-agilent-technologies-latest-guidance-increase-points-toward-brighter-outlook | Agilent raises its FQ1 '21 guide at the recent JPM conference on the back of broad-based strength across its segments and end-markets. The near-term outlook appears bright, underpinned by a cyclical rebound in the Life Science & Applied Markets business, along with continued resilience in the Cross Lab Group. | Agilent Technologies: Latest Guidance Increase Points Toward A Brighter Outlook | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-01-26 11:00:00 | https://www.businesswire.com/news/home/20210126005199/en/Agilent-to-Webcast-First-Quarter-Fiscal-Year-2021-Financial-Results-Presentation/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent to issue first quarter fiscal year 2021 financial results Tuesday, Feb. 16. | Agilent to Webcast First-Quarter Fiscal Year 2021 Financial Results Presentation | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-01-25 08:00:00 | https://www.businesswire.com/news/home/20210125005183/en/Agilent-Announces-Enhanced-Mass-Spectrometry-and-Automation-Software-Solutions-to-Support-Regulatory-Compliance-Guidelines/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of MassHunter Workstation Plus 11.0, MassHunter Networked Workstation 11.0, and MassHunter BioConfirm. The latest revision of these software enables data integrity consistent with the regulatory requirements from the US FDA and EU EMEA guidance, providing user management, checksums, tamper detection, and audit trails for MassHunter Acquisition, Quantitative Analysis, and MassHunter BioConfirm. | Agilent Announces Enhanced Mass Spectrometry and Automation Software Solutions to Support Regulatory Compliance Guidelines | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-01-15 13:37:00 | https://www.businesswire.com/news/home/20210115005526/en/Agilent-Names-Allison-Ballmer-Senior-Vice-President-of-Strategy-and-Corporate-Development/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent names Allison Ballmer senior vice president of Strategy and Corporate Development. | Agilent Names Allison Ballmer Senior Vice President of Strategy and Corporate Development | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2021-01-15 10:48:27 | https://www.gurufocus.com/news/1332546/5-health-care-stocks-gurus-are-buying | According to the GuruFocus All-in-One Screener as of Jan. 15, the following Health Care stocks are popular among gurus. | 5 Health Care Stocks Gurus Are Buying | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2020-12-23 12:03:11 | https://www.zacks.com/stock/news/1201168/why-is-agilent-a-up-24-since-last-earnings-report | Agilent (A) reported earnings 30 days ago. What's next for the stock? | Why Is Agilent (A) Up 2.4% Since Last Earnings Report? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2020-12-22 22:00:00 | https://www.businesswire.com/news/home/20201222005553/en/Agilent-Receives-Approval-for-GenetiSure-Dx-Postnatal-Assay-in-Japan/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced it has obtained clearance from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the GenetiSure Dx Postnatal Assay – a microarray-based assay for diagnostic use. This assay enables clinical geneticists to detect genetic aberrations associated with developmental delay, intellectual disabilities, congenital anomalies, and unexplained dysmorphic features. The company also announced that it has register | Agilent Receives Approval for GenetiSure Dx Postnatal Assay in Japan | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2020-12-16 11:00:00 | https://www.businesswire.com/news/home/20201216005053/en/Agilent-Announces-Webcasts-for-Investment-Community/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces investor webcasts. | Agilent Announces Webcasts for Investment Community | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2020-12-14 08:00:00 | https://www.businesswire.com/news/home/20201214005178/en/Agilent-Receives-Multiple-Innovation-Awards/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that both the NanoDis System and the innovative new style polychromator in the 5800 and 5900 ICP-OES have received Innovation Awards from The Analytical Scientist. The recently launched NanoDis System utilizes cross-flow filtration—a concept traditionally used in industrial process chemistry—combined with conventional dissolution instruments to enable nanoparticle dissolution testing. Along with the introd | Agilent Receives Multiple Innovation Awards | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2020-12-11 10:00:00 | https://www.businesswire.com/news/home/20201211005125/en/Agilent-Releases-2019-Corporate-Social-Responsibility-Report/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent releases 2019 corporate social responsibility report. | Agilent Releases 2019 Corporate Social Responsibility Report | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2020-12-07 00:30:00 | https://www.businesswire.com/news/home/20201206005047/en/Agilent-Presents-Thought-Leader-Award-to-IIT-Delhi-Scientist-Professor-Anurag-Rathore/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has honored Prof. Anurag Rathore, a scientist at the Indian Institute of Technology (IIT) Delhi, with an Agilent Thought Leader Award, for his contributions to the field of biopharmaceutical research and his work with advanced methods for molecular characterization of biosimilars. The 2020 award includes a grant to support research personnel and Agilent instrumentation including a 6545XT AdvanceBio LC/Q-TOF, a Bravo Autom | Agilent Presents Thought Leader Award to IIT Delhi Scientist Professor Anurag Rathore | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2020-12-03 08:00:00 | https://www.businesswire.com/news/home/20201203005115/en/Agilent-Announces-Alissa-Interpret-Selected-by-North-West-Genomic-Laboratory-Hub-for-Clinical-Genomic-Analysis/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its clinical informatics platform Alissa Interpret has been adopted by the North West Genomic Laboratory Hub (NW GLH) based in Manchester and Liverpool, part of Manchester University NHS Foundation Trust, England. The NW GLH and its partners are responsible for delivering genomic testing across the whole of the North West. Alissa Interpret, which enables clinical genetics labs to standardize and automate v | Agilent Announces Alissa Interpret Selected by North West Genomic Laboratory Hub for Clinical Genomic Analysis | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2020-11-30 08:00:00 | https://www.businesswire.com/news/home/20201130005049/en/Agilent-Announces-Launch-of-Global-Biomarker-Pathologist-Training-Program/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Biomarker Pathologist Training Program, a global initiative created to empower pathologists to score biomarkers accurately and confidently. Developed by Agilent – a worldwide leader in developing and commercializing diagnostic products – this training program incorporates Agilent's unique expertise in companion diagnostics and partnership with top pharmaceutical companies. Biomarker testi | Agilent Announces Launch of Global Biomarker Pathologist Training Program | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-11-23 20:15:57 | https://seekingalpha.com/article/4391129-agilent-technologies-inc-ceo-mike-mcmullen-on-q4-2020-results-earnings-call-transcript | Agilent Technologies Inc. (A) CEO Mike McMullen on Q4 2020 Results - Earnings Call Transcript | Agilent Technologies Inc. (A) CEO Mike McMullen on Q4 2020 Results - Earnings Call Transcript | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2020-11-23 16:29:52 | https://www.benzinga.com/news/earnings/20/11/18499664/agilent-technologies-q4-earnings-insights | Shares of Agilent Technologies (NYSE:A) fell 2.53% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 10.11% over the past year to $0.98, which beat the estimate of $0.93. | Agilent Technologies: Q4 Earnings Insights | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2020-11-23 16:05:00 | https://www.businesswire.com/news/home/20201123006172/en/Agilent-Reports-Fourth-Quarter-and-Fiscal-Year-2020-Financial-Results-Initiates-Fiscal-2021-Guidance/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent reports fourth-quarter and fiscal year 2020 financial results; initiates fiscal 2021 guidance. | Agilent Reports Fourth-Quarter and Fiscal Year 2020 Financial Results; Initiates Fiscal 2021 Guidance | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-11-23 09:00:00 | https://seekingalpha.com/article/4390957-dividend-changes-november-14minus-20-2020 | In this article series, we provide a weekly summary of dividend changes. A summary table provides relevant data and key statistics of dividend increases. | Dividend Changes: November 14-20, 2020 | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2020-11-23 08:00:00 | https://www.businesswire.com/news/home/20201123005344/en/Agilent-Launches-New-NanoDis-System-for-Nanoparticle-Dissolution-Testing/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation and software to enable customers to meet 21 CFR Part 11 and other regulations through its application, the new NanoDis System delivers a dedicated workflow that is automatable and auditable. Designed in collaboration with Dr. Emre Türeli from nanoparticle manufacturer MyBiotech GmbH, the NanoDis S | Agilent Launches New NanoDis System for Nanoparticle Dissolution Testing | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2020-11-17 08:32:00 | https://www.businesswire.com/news/home/20201117005814/en/Agilent-Presents-Thought-Leader-Award-to-Drs.-Carl-H.-June-and-Michael-Milone/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced professors Carl H. June, MD, and Michael Milone, MD, Ph.D., as recipients of an Agilent Thought Leader Award. Both scientists are being recognized for their joint contributions to the field of CAR T-cell mediated cancer immunotherapy, having codeveloped tisagenlecleucel (Kymriah™), the first cell and gene therapy product approved by the US FDA. The award will focus on defining standards for the design, val | Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2020-11-13 20:26:00 | https://www.businesswire.com/news/home/20201113005727/en/Agilent-Receives-Expanded-FDA-Approval-for-PD-L1-IHC-22C3-pharmDx-in-Triple-Negative-Breast-Cancer/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as an aid in identifying patients with triple-negative breast cancer (TNBC) for treatment with KEYTRUDA® (pembrolizumab). PD-L1 expression is a critical biomarker for response to anti-PD-1 therapies such as KEYTRUDA. The expanded use of PD-L1 IHC 22C3 pharmDx strengthens the ability of pathologists to identify patients who may be eligible f | Agilent Receives Expanded FDA Approval for PD-L1 IHC 22C3 pharmDx in Triple-Negative Breast Cancer | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2020-11-04 08:00:00 | https://www.businesswire.com/news/home/20201104005128/en/Agilent-Collaborates-With-SGS-to-Release-New-US-EPA-Method-for-the-Analysis-of-Dioxins-Using-GCTQ/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today a collaboration with SGS has resulted in a new GC/TQ method, the SGS AXYS Method 16130, approved by the US EPA as an alternative method for the future regulation and detection of dioxins. Dioxins are a group of chemical compounds that are considered persistent environmental pollutants and subsequently find their way into the food chain. These chemicals are listed as persistent organic pollutants under the | Agilent Collaborates With SGS to Release New US EPA Method for the Analysis of Dioxins Using GC/TQ | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2020-10-29 15:00:00 | https://www.businesswire.com/news/home/20201029006097/en/Agilent-to-Webcast-Fourth-Quarter-Fiscal-Year-2020-Financial-Results-Presentation-Sets-Date-for-Virtual-Analyst-and-Investor-Meeting/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent will release fiscal fourth quarter financial results Mon., Nov. 23. and will also host a virtual analyst and investor event Wed., Dec. 9. | Agilent to Webcast Fourth-Quarter Fiscal Year 2020 Financial Results Presentation, Sets Date for Virtual Analyst and Investor Meeting | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2020-10-26 17:15:00 | https://www.gurufocus.com/news/1267400/bill-ackman-reduces-lowes-agilent-technologies-and-hilton-worldwide-holdings | Bill Ackman (Trades, Portfolio), leader of Pershing Square Capital Management, has revealed his portfolio for the third quarter. | Bill Ackman Reduces Lowe's, Agilent Technologies and Hilton Worldwide Holdings | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-10-22 07:41:03 | https://www.thelincolnianonline.com/2020/10/22/pacer-advisors-inc-sells-4329-shares-of-agilent-technologies-inc-nysea.html | Pacer Advisors Inc. lowered its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 13.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,835 shares of the medical research company’s stock after selling 4,329 shares during the quarter. Pacer Advisors Inc.’s holdings in Agilent […] | Pacer Advisors Inc. Sells 4,329 Shares of Agilent Technologies, Inc. (NYSE:A) | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-10-20 06:40:41 | https://www.thelincolnianonline.com/2020/10/20/agilent-technologies-inc-nysea-shares-purchased-by-ibm-retirement-fund.html | IBM Retirement Fund boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 39.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,053 shares of the medical research company’s stock after buying an additional 2,821 shares during […] | Agilent Technologies, Inc. (NYSE:A) Shares Purchased by IBM Retirement Fund | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
businesswire | 2020-10-20 00:00:00 | https://www.businesswire.com/news/home/20201020005929/en/Validation-of-Bluestar-Genomics%E2%80%99-Technology-for-Non-Invasive-Detection-of-Pancreatic-Cancer-Published-in-Nature-Communications | Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early cancer detection, announced today t | Validation of Bluestar Genomics’ Technology for Non-Invasive Detection of Pancreatic Cancer Published in Nature Communications | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-10-19 06:18:54 | https://www.thelincolnianonline.com/2020/10/19/mission-wealth-management-lp-buys-101-shares-of-agilent-technologies-inc-nysea.html | Mission Wealth Management LP increased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 1.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 9,539 shares of the medical research company’s stock after acquiring an additional 101 shares during the quarter. Mission […] | Mission Wealth Management LP Buys 101 Shares of Agilent Technologies, Inc. (NYSE:A) | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.zonebourse.com | 2020-10-19 06:05:03 | https://www.zonebourse.com/cours/action/QUANTUM-GENOMICS-16253203/actualite/Quantum-Genomics-Quantum-Genomics-conclut-un-accord-de-licence-et-de-collaboration-exclusif-av-31563659/ | Quantum Genomics :
Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Qilu Pharmaceutical | Zone bourse | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
|
https://www.boursorama.com | 2020-10-19 06:00:00 | https://www.boursorama.com/bourse/actualites/quantum-genomics-quantum-genomics-conclut-un-accord-de-licence-et-de-collaboration-exclusif-avec-qilu-pharmaceutical-eed8e1834fb6f1c650130abee1d1b583 | Quantum Genomics recevra jusqu'à 50 M$ de paiements initiaux (upfront) et d'étapes (milestones) ainsi que des royalties à deux chiffres sur les ventes futures.
Qilu Pharmaceutical recevra une licence exclusive pour développer et commercialiser le firibastat pour le traitement de l'hypertension difficile à traiter / résistante en Chine, y compris Hong-Kong et Macao | QUANTUM GENOMICS : Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Qilu Pharmaceutical | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
businesswire | 2020-10-19 00:00:00 | https://www.businesswire.com/news/home/20201019005431/en/Agilent-to-Showcase-Their-Commitment-to-Sustainability-at-analytica-virtual-2020 | Agilent Technologies Inc. (NYSE: A) today announced that their 1220, 1260, and 1290 Infinity II LC product families have received the My Green Lab acc | Agilent to Showcase Their Commitment to Sustainability at analytica virtual 2020 | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-10-18 04:58:41 | https://www.thelincolnianonline.com/2020/10/18/nachman-norwood-parrott-inc-makes-new-investment-in-agilent-technologies-inc-nysea.html | Nachman Norwood & Parrott Inc purchased a new position in Agilent Technologies Inc (NYSE:A) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 515 shares of the medical research company’s stock, valued at approximately $52,000. A number of other institutional investors and hedge funds […] | Nachman Norwood & Parrott Inc Makes New Investment in Agilent Technologies Inc (NYSE:A) | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
businesswire | 2020-10-18 00:00:00 | https://www.businesswire.com/news/home/20201018005038/en/COVID-19-Impact-and-Recovery-Analysis-Laboratory-Equipment-Services-Market-Procurement-Intelligence-Report-Forecasts-Spend-Growth-of-over-USD-24-Billion | Laboratory Equipment Services Market is poised to experience spend growth of more than USD 24 billion between 2020-2024 at a CAGR of over 6.23%. | COVID-19 Impact and Recovery Analysis |Laboratory Equipment Services Market Procurement Intelligence Report Forecasts Spend Growth of over USD 24 Billion | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-10-16 08:16:41 | https://www.thelincolnianonline.com/2020/10/16/cx-institutional-purchases-299-shares-of-agilent-technologies-inc-nysea.html | CX Institutional lifted its position in shares of Agilent Technologies Inc (NYSE:A) by 130.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 528 shares of the medical research company’s stock after acquiring an additional 299 shares during the period. CX […] | CX Institutional Purchases 299 Shares of Agilent Technologies Inc (NYSE:A) | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-10-16 07:22:48 | https://www.thelincolnianonline.com/2020/10/16/regentatlantic-capital-llc-sells-474-shares-of-agilent-technologies-inc-nysea.html | Regentatlantic Capital LLC cut its holdings in Agilent Technologies Inc (NYSE:A) by 7.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,768 shares of the medical research company’s stock after selling 474 shares during the quarter. Regentatlantic Capital LLC’s holdings in […] | Regentatlantic Capital LLC Sells 474 Shares of Agilent Technologies Inc (NYSE:A) | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
businesswire | 2020-10-16 00:00:00 | https://www.businesswire.com/news/home/20201016005166/en/Global-Capillary-Electrophoresis-MarketIncreasing-RD-Expenditure-to-Boost-Market-Growth-Technavio | The Global Capillary Electrophoresis Market will grow by $ 300.97 mn during 2020-2024 | Global Capillary Electrophoresis Market|Increasing R&D Expenditure to Boost Market Growth | Technavio | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
businesswire | 2020-10-15 00:00:00 | https://www.businesswire.com/news/home/20201015005427/en/Global-Treatment-and-Diagnosis-of-Sexually-Transmitted-Diseases-Markets-2025---Focus-on-Antibiotics-AntiviralsAntiretrovirals-EIA-ELISA-PCR-Rapid-Diagnostics---ResearchAndMarkets.com | The | Global Treatment and Diagnosis of Sexually Transmitted Diseases Markets, 2025 - Focus on Antibiotics, Antivirals/Antiretrovirals & EIA, ELISA, PCR, Rapid Diagnostics - ResearchAndMarkets.com | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-10-14 08:14:49 | https://www.thelincolnianonline.com/2020/10/14/agilent-technologies-inc-nysea-shares-acquired-by-envestnet-asset-management-inc.html | Envestnet Asset Management Inc. grew its stake in Agilent Technologies Inc (NYSE:A) by 10.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 256,741 shares of the medical research company’s stock after purchasing an additional 24,832 shares during the period. Envestnet Asset […] | Agilent Technologies Inc (NYSE:A) Shares Acquired by Envestnet Asset Management Inc. | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-10-13 09:14:46 | https://www.thelincolnianonline.com/2020/10/13/agilent-technologies-inc-nysea-stock-position-increased-by-lgt-capital-partners-ltd.html | LGT Capital Partners LTD. increased its stake in shares of Agilent Technologies Inc (NYSE:A) by 3.3% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 829,680 shares of the medical research company’s stock after purchasing an additional 26,210 shares during the period. Agilent Technologies makes […] | Agilent Technologies Inc (NYSE:A) Stock Position Increased by LGT Capital Partners LTD. | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
businesswire | 2020-10-13 00:00:00 | https://www.businesswire.com/news/home/20201012005709/en/DNA-Sequencing-Market-to-Reach-12.5-bn-by-2024-Agilent-Technologies-Inc.-BGI-Genomics-Co.-Ltd.-and-Thermo-Fisher-Scientific-Inc.-Emerge-as-Key-Contributors-to-Growth-Technavio | The Global DNA Sequencing Market will grow by USD 12.5 bn during 2020-2024 | DNA Sequencing Market to Reach $ 12.5 bn by 2024, Agilent Technologies Inc., BGI Genomics Co. Ltd., and Thermo Fisher Scientific Inc., Emerge as Key Contributors to Growth | Technavio | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
investing | 2020-10-12 00:00:00 | https://www.investing.com/analysis/top-sector-etfs-from-wall-streets-best-week-in-3-months-200540731 | Stocks Analysis by Zacks Investment Research covering: S&P 500, Xilinx Inc, NVIDIA Corporation, Advanced Micro Devices Inc. Read Zacks Investment Research's latest article on Investing.com | Top Sector ETFs From Wall Street's Best Week in 3 Months | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
barrons | 2020-10-10 13:00:00 | https://www.barrons.com/articles/their-travel-dreams-upended-retirees-adjust-to-the-pandemic-heres-how-some-are-coping-51602334801 | Normally, travel is the top dream of retirees. But the coronavirus pandemic has changed many retirees’ travel plans, forcing them to adapt on the fly. | Their Travel Dreams Upended, Retirees Adjust to the Pandemic. Here’s How Some Are Coping. | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
businesswire | 2020-10-09 00:00:00 | https://www.businesswire.com/news/home/20201009005283/en/Genomics-Market-Need-for-CreatingUpgrading-Genome-Databases-to-Boost-the-Market-Growth-Technavio | The Global Genomics Market will grow by USD 17.23 bn during 2020-2024 | Genomics Market| Need for Creating/Upgrading Genome Databases to Boost the Market Growth | Technavio | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-10-08 07:56:59 | https://www.thelincolnianonline.com/2020/10/08/agilent-technologies-inc-nysea-shares-sold-by-first-hawaiian-bank.html | First Hawaiian Bank trimmed its holdings in shares of Agilent Technologies Inc (NYSE:A) by 2.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,496 shares of the medical research company’s stock after selling 336 shares during the quarter. First Hawaiian Bank’s holdings in […] | Agilent Technologies Inc (NYSE:A) Shares Sold by First Hawaiian Bank | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-10-08 07:56:56 | https://www.thelincolnianonline.com/2020/10/08/fulton-bank-n-a-has-654000-stock-position-in-agilent-technologies-inc-nysea.html | Fulton Bank N. A. grew its holdings in shares of Agilent Technologies Inc (NYSE:A) by 17.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,480 shares of the medical research company’s stock after buying an additional 957 shares during the quarter. […] | Fulton Bank N. A. Has $654,000 Stock Position in Agilent Technologies Inc (NYSE:A) | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
businesswire | 2020-10-08 00:00:00 | https://www.businesswire.com/news/home/20201007005674/en/Global-Biosensors-in-Life-Sciences-Market-Will-Showcase-Neutral-Impact-During-2020-2024-Advantages-of-Biosensors-in-Drug-Analysis-to-Boost-Market-Growth-Technavio | The Global Biosensors in Life Sciences Market will grow by $ 2.32 bn during 2020-2024 | Global Biosensors in Life Sciences Market Will Showcase Neutral Impact During 2020-2024 | Advantages of Biosensors in Drug Analysis to Boost Market Growth | Technavio | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
marketwatch | 2020-10-07 09:38:03 | https://www.marketwatch.com/press-release/global-womens-health-diagnostics-market-investment-feasibility-2029-with-top-manufactures---agilent-technologies-ariosa-diagnostics-2020-10-07 | Oct 07, 2020 (WiredRelease via Comtex) --
Radical Growth of Global Womens Health Diagnostics Market Provides an updated and current analysis of the... | Global Womens Health Diagnostics Market Investment Feasibility 2029 With Top Manufactures - Agilent Technologies, Ariosa Diagnostics | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |